ORAL PHARMACEUTICAL FORMULATION COMPRISING A SULFONYL BICYCLIC MODULATOR OF PPAR FOR THE TREATMENT OF DISEASE

摘要

Provided herein are oral pharmaceutical formulations of 4-[cis-2,6-dimethyl-4- (4-trifluoromethoxy-phenyl)-piperazine- 1 -sulfonyl]-indan-2-carboxylic acid which may be useful as inhibitors of peroxisome proliferator activated receptors (PPARs) for the treatment or prevention of diseases such as diabetes, hyperglycemia, metabolic syndrome, obesity, or atherosclerosis.